News | January 07, 2023
Dabur India expects low to mid-single digit revenue growth for Q3 FY23
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Purchase agreement with ViewRay will make state-of-the art precision radiation therapy available in China
Seeks partnership between government and private medical colleges for providing superior medical education
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
MVUs will provide diagnosis treatment, vaccination, artificial insemination, minor surgical interventions, audio-visual aids and extension services to farmers/animal owners at their doorstep in far flung areas.
The Government of India is supporting the states in active case detection, surveillance, treatment, supply of diagnostic kits, medicines, sprays etc.
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Subscribe To Our Newsletter & Stay Updated
